Regeneron Pharmaceuticals Inc (REGN)
680.61
-8.89
(-1.29%)
USD |
NASDAQ |
Mar 13, 16:00
685.00
+4.39
(+0.65%)
After-Hours: 20:00
Regeneron Pharmaceuticals Profit Margin (Quarterly): 24.22% for Dec. 31, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 6.90% |
| Eli Lilly and Co | 32.59% |
| Merck & Co Inc | 23.96% |
| Pfizer Inc | 2.31% |
| Moderna Inc | -117.2% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 15.78% |
| Return on Assets | 12.34% |
| Return on Invested Capital | 14.73% |
| Gross Profit Margin (Quarterly) | 85.08% |
| Operating Margin (Quarterly) | 26.50% |
| Return on Net Operating Assets | 31.35% |